RAC-Beta Serine/Threonine-Protein Kinase (AKT2) Antibody
260€ (50 µg)
Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.
935106861
info@markelab.com
name
RAC-Beta Serine/Threonine-Protein Kinase (AKT2) Antibody
category
Primary Antibodies
provider
Abbexa
reference
abx455147
tested applications
ELISA, WB, IHC
Description
RAC-Beta Serine/Threonine-Protein Kinase (AKT2) Antibody is a Rabbit polyclonal antibody for the detection of Human RAC-Beta Serine/Threonine-Protein Kinase (AKT2).
Documents del producto
Instrucciones
Data sheet
Product specifications
| Category | Primary Antibodies |
| Immunogen Target | Target: RAC-Beta Serine/Threonine-Protein Kinase (AKT2) Immunogen: Recombinant RAC-Beta Serine/Threonine-Protein Kinase (Met1-Lys146) expressed in E. coli. |
| Host | Rabbit |
| Reactivity | Human |
| Recommended Dilution | Optimal dilutions/concentrations should be determined by the end user. |
| Clonality | Polyclonal |
| Conjugation | Unconjugated |
| Isotype | IgG |
| Size 1 | 50 µg |
| Size 2 | 100 µg |
| Form | Liquid |
| Tested Applications | ELISA, WB, IHC |
| Buffer | 0.01 M PBS, pH 7.4, 50% glycerol, 0.05% Proclin-300. |
| Availability | Shipped within 5-12 working days. |
| Storage | Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles. |
| Dry Ice | No |
| UniProt ID | P31751 |
| Gene ID | 208 |
| NCBI Accession | NP_001317440.1 |
| Alias | AKT2,PKB beta,Protein kinase Akt ,Protein kinase B beta |
| Background | Antibody anti-AKT2 |
| Status | RUO |
| Note | THIS PRODUCT IS FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC, THERAPEUTIC OR COSMETIC PROCEDURES. NOT FOR HUMAN OR ANIMAL CONSUMPTION. |
Descripción
Related Products
Human AKT2 (RAC-beta serine/threonine-protein kinase) ELISA Kit
Ver Producto
AKT2 antibody
AKT2 is one of 3 closely related serine/threonine-protein kinases (AKT1, AKT2 and AKT3) called the AKT kinase, and which regulate many processes including metabolism, proliferation, cell survival, growth and angiogenesis and their activation has been observed in a wide variety of cancers. AKT2 is mainly involved in cancer cell survival, apoptosis inhibition, migration and invasion(PMID:21979951). The full length protein has four glycosylation sites.
Ver Producto